Evidence map›Paper›PMID 39761305›Full record

ArticlePloS one2025

Effect of power training on function and body composition in older women with probable sarcopenia. A study protocol for a randomized controlled trial.

Luis Polo-Ferrero, Susana Sáez-Gutiérrez, Arturo Dávila-Marcos, Fausto J Barbero-Iglesias, María C Sánchez-Sánchez, Ana Silvia Puente-González, Roberto Méndez-Sánchez

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05870046 (Effectiveness of Power Training Compared With Non-specific Exercises on Functionality and Body Composition in Women Older Than 65 Years With Probable Sarcopenia.), which is not on this map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05870046 nacompletednot on this map

Effectiveness of Power Training Compared With Non-specific Exercises on Functionality and Body Composition in Women Older Than 65 Years With Probable Sarcopenia.

TypeinterventionalSponsorUniversity of SalamancaRan2022 to 2024Enrolled120ConditionsPre-sarcopenia, Old Age, DebilityArmsPower training in women older than 65 years with pre-sarcopenia, Multimodal and nonspecific exercises in women older than 65 years with pre-sarcopenia
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Luis Polo-FerreroDepartment of Nursing and Physiotherapy, University of Salamanca, Salamanca, Spain.ORCID 0000-0002-8349-0441
Susana Sáez-GutiérrezDepartment of Nursing and Physiotherapy, University of Salamanca, Salamanca, Spain.
Arturo Dávila-MarcosDepartment of Nursing and Physiotherapy, University of Salamanca, Salamanca, Spain.
Fausto J Barbero-IglesiasDepartment of Nursing and Physiotherapy, University of Salamanca, Salamanca, Spain.
María C Sánchez-SánchezDepartment of Nursing and Physiotherapy, University of Salamanca, Salamanca, Spain.ORCID 0000-0002-7391-4394
Ana Silvia Puente-GonzálezDepartment of Nursing and Physiotherapy, University of Salamanca, Salamanca, Spain.
Roberto Méndez-SánchezDepartment of Nursing and Physiotherapy, University of Salamanca, Salamanca, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSarcopenia is a clinical syndrome characterized by the loss of muscle mass and strength. Hormonal changes that occur early in women may influence protein synthesis and promote muscle atrophy, leading to probable sarcopenia, defined as a loss of muscle strength without an obvious decrease in muscle mass. Various types of exercise have already proven effective in treating sarcopenia. Power training (PT), a subtype of resistance training performed at high speed, has not yet been studied in this population group.

methodsA randomized controlled trial will be conducted with three parallel groups: a PT group, a multicomponent training (MT) group, and a no-exercise group. The inclusion criteria will be women over 65 years of age who meet the diagnostic criteria for probable sarcopenia (Hand grip test less than 16 kg and Five Times Sit to Stand Test more than 15 s) according to the European Working Group on Sarcopenia in Older People (EWGSOP2). Two assessments will be conducted at the beginning and at the end of the 32 weeks of intervention, in which variables of body composition (muscle, fat and weight) and functionality (strength and physical performance) will be collected. There will be 3 sessions of 50 minutes per week in each intervention group. The masking strategy will be double-blind. The analysis of intergroup differences will be conducted using multivariate and univariate analysis of variance (MANOVA and ANOVA), as well as pairwise comparisons (Bonferroni corrections). Changes in the degree of sarcopenia and how many women eliminate the risk of sarcopenia (no probable sarcopenia) after the different interventions will be tested. DISCUSSION: The study aims to investigate the impact of PT in older women at risk of sarcopenia. The expected results are that PT will significantly improve functionality and body composition compared to other forms of exercise (MT) and no physical activity. The results may represent a significant advance in understanding and addressing sarcopenia before it becomes established, providing preventive treatment and new tools whose clinical applicability has been studied.

trial registrationThe clinical trial was prospectively registered at ClinicalTrials.gov Identifier: NCT05870046.

Indexed as

Body CompositionResistance TrainingSarcopeniaAgedAged, 80 and overDouble-Blind MethodFemaleHand StrengthHumansMuscle StrengthRandomized Controlled Trials as Topic

Identifiers

PMID39761305
PMCPMC11703083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.